ReviewCurrent hematologic malignancy reports2016
Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment.
Taiga Nishihori et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it